{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:23:35Z","timestamp":1791563015987,"version":"4.3.4"},"update-to":[{"DOI":"10.1002\/14651858.cd015723","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000}}],"reference-count":59,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd015723.pub2","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T11:52:41Z","timestamp":1764935561000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Medical and surgical interventions for neurotrophic keratopathy"],"prefix":"10.1002","volume":"2025","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7153-3889","authenticated-orcid":false,"given":"Zanna","family":"Kruoch","sequence":"additional","affiliation":[{"name":"College of Optometric Medicine; Rocky Mountain University of Health Professions; Provo Utah USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeline YM","family":"Choo","sequence":"additional","affiliation":[{"name":"Icahn School of Medicine at Mount Sinai; New York New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Kemp","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences; University of Houston, College of Optometry; Houston Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Gonzales","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences; University of Houston, College of Optometry; Houston Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsz Wing","family":"Yim","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology; University of Colorado Anschutz Medical Campus; Aurora Colorado USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"McCann","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology; University of Colorado Anschutz Medical Campus; Aurora Colorado USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Hsun","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology; University of Colorado Anschutz Medical Campus; Aurora Colorado USA"},{"name":"Department of Epidemiology; Colorado School of Public Health; Aurora Colorado USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1081-1141","authenticated-orcid":false,"given":"Darren Shu Jeng","family":"Ting","sequence":"additional","affiliation":[{"name":"Academic Ophthalmology, Department of Inflammation and Ageing, School of Infection, Inflammation, and Immunology; College of Medicine and Health, University of Birmingham; Birmingham UK"},{"name":"Birmingham and Midland Eye Centre; Sandwell and West Birmingham NHS Trust; Birmingham UK"},{"name":"Academic Ophthalmology, School of Medicine; University of Nottingham; Nottingham UK"},{"name":"Ophthalmology and Visual Sciences Academic Clinical Program (EYE-ACP); Duke-NUS Medical School; Singapore Singapore"},{"name":"Singapore National Eye Centre; Singapore Eye Research Institute; Singapore Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene C","family":"Kuo","sequence":"additional","affiliation":[{"name":"Wilmer Eye Institute; Johns Hopkins University School of Medicine; Baltimore Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"key":"10.1002\/14651858.CD015723.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.preteyeres.2018.04.003","article-title":"Neurotrophic keratopathy","volume":"66","author":"Dua","year":"2018","journal-title":"Progress in Retinal Eye Research"},{"key":"10.1002\/14651858.CD015723.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1007\/s00417-021-05535-z","article-title":"Incidence, prevalence, and outcome of moderate to severe neurotrophic keratopathy in a German tertiary referral center from 2013 to 2017","volume":"260","author":"Roth","year":"2022","journal-title":"Graefe's Archive for Clinical and Experimental Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD015723.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000511011","article-title":"Clinical spectrum and outcomes of ocular and periocular complications following external-beam radiotherapy for inoperable malignant maxillary sinus tumors","volume":"7","author":"Ting","year":"2021","journal-title":"Ocular Oncology and Pathology"},{"key":"10.1002\/14651858.CD015723.pub2-BIB0004|cit4","first-page":"571","article-title":"Diagnosis and management of neurotrophic keratitis","volume":"8","author":"Sacchetti","year":"2014","journal-title":"Clinical Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD015723.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/jcp.25623","article-title":"Understanding the pathogenesis of neurotrophic keratitis: the role of corneal nerves","volume":"232","author":"Mastropasqua","year":"2017","journal-title":"Journal of Cellular Physiology"},{"issue":"4","key":"10.1002\/14651858.CD015723.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/ICU.0000000000000766","article-title":"The management of neurotrophic keratitis","volume":"32","author":"Jabbour","year":"2021","journal-title":"Current Opinion in Ophthalmology"},{"issue":"11","key":"10.1002\/14651858.CD015723.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.ophtha.2022.06.019","article-title":"Neurotrophic keratopathy in the United States: an intelligent research in sight registry analysis","volume":"129","author":"Bian","year":"2022","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD015723.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/ICL.0000000000000757","article-title":"On the horizon: biologics and nutrients for neurotrophic keratitis","volume":"47","author":"Gumus","year":"2021","journal-title":"Eye and Contact Lens"},{"issue":"3","key":"10.1002\/14651858.CD015723.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/00003226-200005000-00003","article-title":"Tetracyclines and the treatment of corneal stromal ulceration: a review","volume":"19","author":"Ralph","year":"2000","journal-title":"Cornea"},{"issue":"8","key":"10.1002\/14651858.CD015723.pub2-BIB0010|cit10","first-page":"2623","article-title":"Efficacy of treatments for neurotrophic keratopathy: a systematic review and meta-analysis","volume":"260","author":"Roumeau","year":"2022","journal-title":"Graefe's Archive for Clinical and Experimental Ophthalmology"},{"key":"10.1002\/14651858.CD015723.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"108115","DOI":"10.1016\/j.exer.2020.108115","article-title":"Biological functions of tear film","volume":"197","author":"Pflugfelder","year":"2020","journal-title":"Experimental Eye Research"},{"key":"10.1002\/14651858.CD015723.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/805876","article-title":"Congenital corneal anesthesia and neurotrophic keratitis: diagnosis and management","volume":"2015","author":"Mantelli","year":"2015","journal-title":"BioMed Research International"},{"issue":"14","key":"10.1002\/14651858.CD015723.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"DES121","DOI":"10.1167\/iovs.17-23760","article-title":"Autologous serum and serum components","volume":"59","author":"Higuchi","year":"2018","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"1","key":"10.1002\/14651858.CD015723.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4103\/tjo.tjo_5_20","article-title":"Amniotic membrane transplantation for managing dry eye and neurotrophic keratitis","volume":"10","author":"Mead","year":"2020","journal-title":"Taiwan Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD015723.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.2147\/OPTH.S185184","article-title":"Update on cenegermin eye drops in the treatment of neurotrophic keratitis","volume":"13","author":"Sheha","year":"2019","journal-title":"Clinical Ophthalmology"},{"issue":"12","key":"10.1002\/14651858.CD015723.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.ophtha.2022.08.014","article-title":"Efficacy of recombinant human nerve growth factor in stage 1 neurotrophic keratopathy","volume":"129","author":"Saricay","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD015723.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"13007","DOI":"10.1038\/s41598-021-92366-x","article-title":"Amniotic membrane transplantation for infectious keratitis: a systematic review and meta-analysis","volume":"11","author":"Ting","year":"2021","journal-title":"Scientific Reports"},{"issue":"3","key":"10.1002\/14651858.CD015723.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/ICL.0000000000000753","article-title":"Surgical management of the ocular surface in neurotrophic keratopathy: amniotic membrane, conjunctival grafts, lid surgery, and neurotization","volume":"47","author":"Trinh","year":"2021","journal-title":"Eye and Contact Lens"},{"issue":"1","key":"10.1002\/14651858.CD015723.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/bjophthalmol-2018-312104","article-title":"Update on corneal neurotisation","volume":"103","author":"Malhotra","year":"2018","journal-title":"British Journal of Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD015723.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/ICO.0000000000001522","article-title":"Corneal neurotization for neurotrophic keratopathy: clinical outcomes and In vivo confocal microscopic and histopathological findings","volume":"37","author":"Ting","year":"2018","journal-title":"Cornea"},{"issue":"2","key":"10.1002\/14651858.CD015723.pub2-BIB0021|cit21","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD015723","article-title":"Medical and surgical interventions for neurotrophic keratopathy","author":"Kruoch","year":"2023","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD015723.pub2-BIB0022|cit22","unstructured":"Higgins JP Lasserson T Thomas J Flemyng E Churchill R Methodological expectations of Cochrane intervention reviews. Cochrane: London. Version August 2023 Available from https:\/\/community.cochrane.org\/mecir-manual"},{"key":"10.1002\/14651858.CD015723.pub2-BIB0023|cit23","first-page":"n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2020","journal-title":"BMJ"},{"issue":"10","key":"10.1002\/14651858.CD015723.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/j.ophtha.2010.07.010","article-title":"Corneal sensation and subbasal nerve alterations in patients with herpes simplex keratitis: an in vivo confocal microscopy study","volume":"117","author":"Hamrah","year":"2010","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD015723.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jtos.2017.12.001","article-title":"Corneal nerve regeneration after herpes simplex keratitis: a longitudinal in vivo confocal microscopy study","volume":"16","author":"Moein","year":"2018","journal-title":"Ocular Surface"},{"issue":"5","key":"10.1002\/14651858.CD015723.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.exer.2011.02.016","article-title":"Assessing the sensory function of the ocular surface: implications of use of a non-contact air jet aesthesiometer versus the Cochet\u2013Bonnet aesthesiometer","volume":"92","author":"Golebiowski","year":"2011","journal-title":"Experimental Eye Research"},{"key":"10.1002\/14651858.CD015723.pub2-BIB0027|cit27","unstructured":"Lefebvre C Glanville J Briscoe S Featherstone R Littlewood A Marshall C Chapter 4: Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated October 2023). Cochrane, 2023 Available from https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/archive\/v6.4"},{"key":"10.1002\/14651858.CD015723.pub2-BIB0028|cit28","unstructured":"Covidence Veritas Health Innovation 2022"},{"key":"10.1002\/14651858.CD015723.pub2-BIB0029|cit29","unstructured":"Review Manager Web (RevMan Web) The Cochrane Collaboration 2024"},{"key":"10.1002\/14651858.CD015723.pub2-BIB0030|cit30","unstructured":"Higgins JP Savovi\u0107 J Page MJ Elbers RG Sterne JAC Chapter 8: Assessing risk of bias in a randomized trial. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane, 2023 Available from https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/archive\/v6.4"},{"key":"10.1002\/14651858.CD015723.pub2-BIB0031|cit31","unstructured":"Deeks JJ Higgins JP Altman DG Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane, 2023 Available from https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/archive\/v6.4"},{"key":"10.1002\/14651858.CD015723.pub2-BIB0032|cit32","unstructured":"Higgins JP Li T Deeks JJ Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane, 2023 Available from https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/archive\/v6.4"},{"key":"10.1002\/14651858.CD015723.pub2-BIB0033|cit33","unstructured":"Higgins JP Eldridge S Li T Chapter 23: Including variants on randomized trials (last updated October 2019). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD015723.pub2-BIB0034|cit34","unstructured":"Page MJ Higgins JP Sterne JA Chapter 13: Assessing risk of bias due to missing results in a synthesis. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane, 2023 Available from https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/archive\/v6.4"},{"key":"10.1002\/14651858.CD015723.pub2-BIB0035|cit35","unstructured":"McKenzie JE Brennan SE Chapter 12: Synthesizing and presenting findings using other methods (last updated October 2019). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.5 (updated August 2024). Cochrane, 2024. Available from https:\/\/www.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD015723.pub2-BIB0036|cit36","unstructured":"Sch\u00fcnemann HJ Higgins JP Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane, 2023 Available from https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/archive\/v6.4"},{"key":"10.1002\/14651858.CD015723.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.ophtha.2018.02.022","article-title":"Phase II randomized, double-masked, vehicle-controlled trial of recombinant human nerve growth factor for neurotrophic keratitis","volume":"125","author":"Bonini","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD015723.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.ophtha.2018.03.004","article-title":"Phase I trial of recombinant human nerve growth factor for neurotrophic keratitis","volume":"125","author":"Bonini","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD015723.pub2-BIB0039|cit39","unstructured":"Evaluation of safety and efficacy of rhNGF in patients with stage 2 and 3 neurotrophic keratitis. (REPARO) https:\/\/clinicaltrials.gov\/study\/NCT01756456"},{"key":"10.1002\/14651858.CD015723.pub2-BIB0040|cit40","first-page":"1172","article-title":"Phase I\/II randomized, double-masked, vehicle-controlled trial of recombinant human nerve growth factor (rhNGF) eye drops in stage 2\/3 neurotrophic keratitis","volume":"58","author":"Mantelli","year":"2017","journal-title":"Investigative Ophthalmology and Visual Science"},{"key":"10.1002\/14651858.CD015723.pub2-BIB0041|cit41","doi-asserted-by":"crossref","unstructured":"Ting DS Re: Bonini et al.: Phase 2 randomized, double-masked, vehicle-controlled trial of recombinant human nerve growth factor for neurotrophic keratitis Ophthalmology 2019 126 E14 5","DOI":"10.1016\/j.ophtha.2018.09.017"},{"key":"10.1002\/14651858.CD015723.pub2-BIB0042|cit42","first-page":"4690","article-title":"Phase I\/II dose-ranging, randomized clinical trial of recombinant human nerve growth factor in the treatment of neurotrophic keratitis: preliminary results","volume":"55","author":"Sinigaglia","year":"2014","journal-title":"Investigative Ophthalmology and Visual Science"},{"key":"10.1002\/14651858.CD015723.pub2-BIB0043|cit43","unstructured":"An 8-week phase I\/II, multicenter, randomized, double-masked, vehicle controlled parallel group study with a 48 or 56 week follow-up period to evaluate the safety and efficacy of two doses https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2012-002527-15\/GB"},{"key":"10.1002\/14651858.CD015723.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"E15","DOI":"10.1016\/j.ophtha.2018.09.018","article-title":"Reply","volume":"126","author":"Bonini","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD015723.pub2-BIB0045|cit45","unstructured":"Study brand name: REPARO Study full title: an 8-week phase I\/II, multicenter, randomized, double-masked, vehicle controlled parallel group study with a 48 or 56 week follow-up period to evaluate the safety and efficacy of two doses (10 \u00b5g\/ml and 20 \u00b5g\/ml of recombinant human nerve growth factor eye drops solution versus vehicle in patients with Stage 2 and 3 of neurotrophic keratitis https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=EUCTR2012-002527-15-PT"},{"key":"10.1002\/14651858.CD015723.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/s12886-020-01584-w","article-title":"Topical citicoline and vitamin B12 versus placebo in the treatment of diabetes-related corneal nerve damage: a randomized double-blind controlled trial","volume":"20","author":"Fogagnolo","year":"2020","journal-title":"BMC Ophthalmology"},{"key":"10.1002\/14651858.CD015723.pub2-BIB0047|cit47","unstructured":"Evaluation of the efficacy of OMK2 in recovering corneal neural damage in patients with diabetes https:\/\/clinicaltrials.gov\/study\/NCT03906513"},{"key":"10.1002\/14651858.CD015723.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/01.ico.0000153102.19776.80","article-title":"Amniotic membrane transplantation in refractory neurotrophic corneal ulcers: a randomized, controlled clinical trial","volume":"24","author":"Khokhar","year":"2005","journal-title":"Cornea"},{"key":"10.1002\/14651858.CD015723.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ophtha.2019.08.020","article-title":"Topical recombinant human nerve growth factor (Cenegermin) for neurotrophic keratopathy: a multicenter randomized vehicle-controlled pivotal trial","volume":"127","author":"Pflugfelder","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD015723.pub2-BIB0050|cit50","unstructured":"Evaluation of efficacy of 20 \u00b5g\/\u200bml rhNGF new formulation (with anti-oxidant) in patients with stage 2 and 3 NK https:\/\/clinicaltrials.gov\/study\/NCT02227147"},{"key":"10.1002\/14651858.CD015723.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3390\/ijms24010554","article-title":"0.1% RGN-259 (Thymosin \u00df4) ophthalmic solution promotes healing and improves comfort in neurotrophic keratopathy patients in a randomized, placebo-controlled, double-masked phase iii clinical trial","volume":"24","author":"Sosne","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1002\/14651858.CD015723.pub2-BIB0052|cit52","unstructured":"Assessment of the safety and efficacy study of RGN-259 ophthalmic solutions for neurotrophic keratopathy: SEER-1 https:\/\/clinicaltrials.gov\/study\/NCT02600429"},{"key":"10.1002\/14651858.CD015723.pub2-BIB0053|cit53","unstructured":"SEER-3: a phase 3, multi-center, randomized, parallel, double masked, placebo-controlled clinical study to assess the safety and efficacy of 0.1% RGN-259 ophthalmic solution for the treatment of neurotrophic keratopathy https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=CTIS2022-502697-16-00"},{"key":"10.1002\/14651858.CD015723.pub2-BIB0054|cit54","unstructured":"Efficacy and safety assessment of T4020 versus vehicle in patients with chronic neurotrophic keratitis or corneal ulcer https:\/\/clinicaltrials.gov\/study\/NCT01794312"},{"issue":"1","key":"10.1002\/14651858.CD015723.pub2-BIB0055|cit55","first-page":"22","article-title":"The effect of recombinant bovine basic fibroblast growth factor on the LASIK-induced neurotrophic epitheliopathy and the recovery of corneal sensation after LASIK","volume":"47","author":"Huang","year":"2011","journal-title":"Zhonghua Yan Ke Za Zhi"},{"key":"10.1002\/14651858.CD015723.pub2-BIB0056|cit56","unstructured":"Open Science Framework Data set for: Medical and surgical interventions for neurotrophic keratopathy (review) https:\/\/osf.io\/6q4f2\/"},{"key":"10.1002\/14651858.CD015723.pub2-BIB0057|cit57","unstructured":"Cenegermin (Oxervate): CADTH reimbursement recommendation: indication: for the treatment of moderate (persistent epithelial defect) or severe (corneal ulcer) neurotrophic keratitis in adults [Internet] Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jul. Table 3, Cost and Cost-Effectiveness https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK603598\/table\/t03\/"},{"key":"10.1002\/14651858.CD015723.pub2-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s41669-019-0138-z","article-title":"Cenegermin for treating neurotrophic keratitis: an evidence review group perspective of a NICE single technology appraisal","volume":"3","author":"Fleeman","year":"2019","journal-title":"Pharmacoeconomics Open"},{"key":"10.1002\/14651858.CD015723.pub2-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ajo.2023.01.025","article-title":"Cost and prescriber and patient characteristics of cenegermin use in the Medicare population","volume":"250","author":"Dai","year":"2023","journal-title":"American Journal of Ophthalmology"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T09:18:45Z","timestamp":1788859125000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD015723.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":59,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd015723.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]}}}